ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:02:04 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual Feature analysis: gain_cnaPANCAN91_(MYC)
Feature details and cell panel numbers
Binary feature equal to 1 for samples having the genomic region(s) cnaPANCAN91_(MYC) amplified (see genomic region decoding file for further infos on this region)
Number of cell lines positive for this feature: 177
Statistically significant associations identified = 3
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a226 |
gain_cnaPANCAN91_(MYC) |
1033 |
1 |
1 |
Vismodegib |
SMO |
157 |
690 |
2.3 |
4.4 |
4.32 |
-0.0863 |
0.099 |
0.1 |
0.095 |
1.19e-04 |
1.64e-25 |
4.44e-01 |
8.7 |
a325 |
gain_cnaPANCAN91_(MYC) |
266 |
1 |
1 |
Zibotentan, ZD4054 |
Endothelin A Receptor |
167 |
752 |
3 |
5.49 |
5.46 |
-0.025 |
0.044 |
0.045 |
0.039 |
2.95e-04 |
1.48e-49 |
1.86e-01 |
15 |
a467 |
gain_cnaPANCAN91_(MYC) |
302 |
1 |
1 |
PI-103 |
PI3Ka, PRKDC (DNAPK) |
166 |
746 |
2.33 |
1.11 |
0.754 |
-0.355 |
0.15 |
0.15 |
0.16 |
6.09e-04 |
3.56e-44 |
3.67e-01 |
22 |
All-tests volcano plot